H.R. 1432

119 HR 1432 IH: Let Injured Americans Be Legally Empowered Act
 U.S. House of Representatives
 2025-02-18
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 1432  IN THE HOUSE OF REPRESENTATIVES   February 18, 2025   Mr. Roy  (for himself,  Mr. Massie ,  Mr. Brecheen ,  Mr. Cloud ,  Mr. Higgins of Louisiana ,  Mr. Crane ,  Mr. Gosar , and  Mr. Perry ) introduced the following bill; which was referred to the  Committee on the Judiciary    A BILL
To prohibit any Federal law from making the manufacturer of a COVID–19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID–19 vaccine, and for other purposes.
1.
Short title
This Act may be cited as the   Let Injured Americans Be Legally Empowered Act   or the   LIABLE Act  .
2.
No Federal immunity from, or limitation on, liability for manufacturers for loss caused by a COVID–19 vaccine
(a)
In general
No Federal law, including sections 319F–3, 2111, and 2122 of the Public Health Service Act (42 U.S.C. 247d–6d, 300aa–11, 300aa–22), may make the manufacturer of a COVID–19 vaccine immune from suit or liability, or limit the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID–19 vaccine.
(b)
Rule of construction
Nothing in this Act shall be construed to prohibit an individual from seeking compensation through the Countermeasures Injury Compensation Program under section 319F–4 of the Public Health Service Act ( 42 U.S.C. 247d–6e ) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act ( 42 U.S.C. 300aa–10 et seq. ).
(c)
Relation to other programs
An individual shall not be precluded from bringing a civil action for claims described in subsection (a) on the basis of such individual having sought or received compensation through the Countermeasures Injury Compensation Program under section 319F–4 of the Public Health Service Act ( 42 U.S.C. 247d–6e ) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act ( 42 U.S.C. 300aa–10 et seq. ).
(d)
Definition
The term  COVID–19 vaccine  means a vaccine licensed or otherwise authorized by the Food and Drug Administration to prevent, mitigate, or limit—
(1)
the harm from COVID–19; or
(2)
the transmission of SARS–CoV–2 or a virus mutating therefrom.
(e)
Retroactive applicability
This Act applies without regard to whether the adminstration or use of a COVID–19 vaccine occurs before, on, or after the date of enactment of this Act.